Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: AMD1, a cardiotoxicity target for Maduramicin

Fig. 2

Maduramicin myocardial injury in H9c2 cells. (a) CCK-8 for the choice of the Mad’s concentration. (b) Morphology and quantity of the H9c2 cells under the light microscope. Control: x100 (plotting scale: 50 μm), Mad: x200 (plotting scale: 100 μm) (c) Flow cytometry to observe H9c2 cell apoptosis. (d)&(e) The protein expression of AMD1 with Western blotting. *P < 0.05. (f)&(g) The protein expression of Caspase-3 with Western blotting. ****P < 0.0001

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us